QSI News and Press, Quantum-Si Incorporated From 08/16/21

Quantum-Si Solidifies Financial Strength and Continues Systematic Commercialization Strategy Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si” or the “Company”), a company pioneering next-generation semiconductor chip-based proteomics, today ann...

Quantum-Si Incorporated, a company pioneering next-generation semiconductor chip-based proteomics, today announced that it has rescheduled its conference call to report second quarter 2021 financial results to August 16, 2021, after market close. John Stark, Chief Executive Officer,...

Proteomics is a rising star in the multi-omics space. Semiconductor chips specifically designed to identify biology brings the advantages of scalability and Moore's law. That's exactly what Quantum-Si is bringing to market. For further details see: Quantum-Si: Merging Se...

Quantum-Si Incorporated, a company pioneering next-generation semiconductor chip-based proteomics, today announced that it will report second quarter 2021 financial results on August 12, 2021, before market open. John Stark, Chief Executive Officer, and Claudia Drayton, Chief Financ...

Proteomics has the potential to revolutionize medicine in potentially the same way that genomics has. The traditional field looks primed for disruption and that effort could hit critical mass soon. Quantum-Si has set forth a business plan to utilize consumables as the primary driver o...

In today's video I look at fundamentals and recent news for Quantum-Si (NASDAQ: QSI) and UiPath (NYSE: PATH) . ARK Investment has recently purchased these two companies that have strong growth potential as long-term investments. Below I share a ...

BSQUARE Corporation (BSQR) +77%.Exela Technologies (XELA) +59% after rollout of its Robotic Process Automation platform.Cerevel Therapeutics Holdings (CERE) +40% after positive results from its early-stage trial of CVL-231.Auddia (AUUD) +37% after launching its flagship app.Ver...

Quantum-Si Incorporated , a company pioneering next-generation semiconductor chip-based proteomics, announced today that it has entered into a lease agreement with Phase 3 Real Estate Partners, Inc. to develop a 25,586-square-foot product development and operations facility in San D...